Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.

IF 2 4区医学 Q3 ONCOLOGY

Oncology-New York Pub Date : 2026-07-22 DOI:10.46883/2026.25921234

José Luis Rodríguez-Olivares, Mauricio Mora Pineda Md, Evelyn Beas-Lozano, Alec Seidman-Sorsby Md, Yuly A Remolina-Bonilla, Armando Gamboa-Domínguez Md, Jeffrey Weitzel Md Facmg, Pedro Barata Md MSc, Yanin Chavarri-Guerra Md MSc Fasco, María T Bourlon

引用次数: 0

Abstract

This cross-sectional study evaluated the genetic landscape of a cohort of patients with metastatic prostate cancer who were treated at a referral center in Mexico City, Mexico.

查看原文本刊更多论文

同源重组和错配修复评估男性晚期前列腺癌：来自墨西哥城一个中心的横断面研究。

本横断面研究评估了在墨西哥墨西哥城转诊中心接受治疗的转移性前列腺癌患者队列的遗传景观。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oncology-New York 肿瘤学-肿瘤学

CiteScore

1.60

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.